相关实验视频

Updated: May 1, 2026

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells

Published on: August 5, 2016

间接血结定量测试用于诊断血病:过去,现在和未来

M M Mikailov¹, Sh A Gunashev¹, E A Yanikova¹

¹Laboratory of Infectious Pathology of Farm Animals, Caspian Zonal Research Veterinary Institute, Makhachkala, Dagestan, Russia.

Veterinary world

|May 27, 2024

概括

通过间接血结定试验 (IHA) 可以改善血结症的诊断. 这次审查强调了IHA的重点.

科学领域:

兽医医学兽医医学兽医医学
传染性疾病传染性疾病
免疫学免疫学免疫学

背景情况:

兽病是一种严重的动物传播疾病,影响着全球的牲畜和公共卫生.
全球旅游和移民的增加挑战了无疾病的地位,需要有效的诊断工具.
目前常规的血清检测有局限性和不一致的结果.

研究的目的:

审查间接血结定量 (IHA) 试验的开发和应用,以诊断血病.
与传统方法相比,评估IHA的诊断价值.
确定未来的方向,以提高IHA在布鲁塞洛斯检测中的有效性.

主要方法:

对用于布鲁塞洛症诊断的间接血结定量 (IHA) 研究的系统综述.
对IHA的可靠性,可负担性和协议简单性的分析.
与已建立的血清学测试 (例如ELISA,CFT) 进行IHA性能比较.

主要成果:

间接血凝试验 (IHA) 是一种可靠,具有成本效益的布鲁塞洛症诊断方法.
IHA在识别常规测试中可疑或假阴性结果方面具有特别的价值.
现有的研究,主要来自俄语出版物,支持IHA的诊断实用性.

结论:

间接血凝定试验 (IHA) 为布鲁塞洛症诊断提供了一种有价值的替代方法,尤其是在传统方法不足的情况下.
需要进一步的研究和更广泛的传播发现,以充分建立IHA在布鲁塞洛斯控制中的全球作用.
优化IHA协议可以增强其用于各种传染病的应用,而不仅仅是乳病.

关键词:

这种疾病的发病地址是:brucellosis.它具有诊断价值的诊断价值.间接血结定量测试试验改善测试方法的前景.血清学测试血清学测试血清学测试

更多相关视频

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology

Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology

Published on: January 24, 2025

相关概念视频

Blood Transfusion and Agglutination

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...

Blood Studies I: ABG and VBG

Blood Studies I: ABG and VBG

Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...